Editorial
Accepted on 07 Apr 2025
Editorial: Monocyte heterogeneity and plasticity
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1601503
Type at least 3 characters
43,152 articles
Review
Accepted on 07 Apr 2025
Advances in Neutrophil Extracellular Traps and Ferroptosis in Sepsisinduced Cardiomyopathy
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1590313
Original Research
Accepted on 07 Apr 2025
Single-Cell Transcriptome Reveals Potential Mechanisms for gout in Children
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1577109
Review
Accepted on 07 Apr 2025
Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1577105
Mini Review
Accepted on 07 Apr 2025
The Role of Monocytes and Macrophages in the Progression of Alzheimer's Disease
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1590909
Original Research
Accepted on 07 Apr 2025
Comprehensive analysis of SQOR involvement in ferroptosis resistance of pancreatic ductal adenocarcinoma in hypoxic environments
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1513589
Review
Accepted on 07 Apr 2025
Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1564603
Review
Accepted on 07 Apr 2025
Ubiquitination in Lipid Metabolism Reprogramming: Implications for Pediatric Solid Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554311
Original Research
Accepted on 07 Apr 2025
In vitro study: HIF-1α-dependent Glycolysis Enhances NETosis in Hypoxic Conditions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1583587
Review
Accepted on 07 Apr 2025
Dual Regulatory Effects of Gut Microbiota and Their Metabolites in Rheumatoid Arthritis: Balancing Pathogenic and Protective Mechanisms
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1584023
Original Research
Accepted on 07 Apr 2025
Safety and necessity of omitting mediastinal lymph node dissection in cN0/N1 non-small cell lung cancer after neoadjuvant immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1587658
Case Report
Accepted on 07 Apr 2025
Subacute Cutaneous Lupus Erythematosus Triggered by Sintilimab: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544312
Correction
Accepted on 07 Apr 2025
Corrigendum: Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1606194
Brief Research Report
Accepted on 07 Apr 2025
Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545579
Original Research
Accepted on 07 Apr 2025
Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560468
Case Report
Accepted on 07 Apr 2025
Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1588471